Randomized clinical trial showed improved HbA1c and blood pressure in adults with type 2 diabetes, suggesting mobile messaging can enhance cardiovascular disease management.
Key Points
Mobile message-based intervention achieved significant HbA1c reduction of −2.8% after 12 months of use.
Participants in the intervention group had higher controlled HbA1c rates at 54.0% compared to 46.1% in usual care.
The study involved a randomized clinical trial of 819 adults with uncontrolled type 2 diabetes in China.
Results indicate that mobile messaging may effectively enhance glycemic control and lower cardiovascular risks.